Skip to content
Advertisement

Production personnel perform a visual inspection of filled vaccine vials inside the Incepta plant on the outskirts of Dhaka in Bangladesh Saturday Feb. 13, 2021. In an industrial neighborhood on the outskirts of Bangladesh's largest city lies a factory with gleaming new equipment imported from Germany, its immaculate hallways lined with hermetically sealed rooms. Yet the factory is operating at just a quarter of its capacity. It is one of three factories that The Associated Press found on three continents whose owners say they could start producing hundreds of millions of COVID-19 vaccines on short notice if only they had the blueprints and technical know-how. (AP Photo/Al-emrun Garjon)

Production personnel perform a visual inspection of filled vaccine vials inside the Incepta plant on the outskirts of Dhaka in Bangladesh Saturday Feb. 13, 2021. In an industrial neighborhood on the outskirts of Bangladesh's largest city lies a factory with gleaming new equipment imported from Germany, its immaculate hallways lined with hermetically sealed rooms. Yet the factory is operating at just a quarter of its capacity. It is one of three factories that The Associated Press found on three continents whose owners say they could start producing hundreds of millions of COVID-19 vaccines on short notice if only they had the blueprints and technical know-how. (AP Photo/Al-emrun Garjon)

Featured Photo Galleries